Bristol Myers Squibb (BMS) has agreed as part of a deal with the US government to provide Eliquis (apixaban) free of charge ...

For decades, modern medicine has treated the mouth and the body as separate entities. But for Dr. Nieca Goldberg, a renowned ...

Gilead has appointed Keeley Wettan as Executive Vice President, General Counsel, Legal & Compliance. In her new role, she ...

Eli Lilly has announced that it has entered into a definitive agreement to acquire Ventyx Biosciences, a biopharmaceutical ...

Over 3.4 million people globally are affected by SLE, and it is one of the leading causes of death in young women in the US ...

Inizio, a leading global commercialization partner for pharma and life sciences, today unveiled Inizio Ignite, a reimagined, ...

The MM+M Podcast features a conversation with Jamie Avallone, Chief Data Officer at Inizio Evoke, and Iris Lin, Product ...

GlaxoSmithKline’s (GSK) Nucala (mepolizumab) has been approved by the MHRA to treat adults with uncontrolled chronic ...

Amgen has announced a deal with the US government that will lower the company’s prescription drug costs for US patients while ...

Novartis has announced an agreement with the US government to lower the prices of its medicines in the US and support ...

As part of the three-year agreement, Gilead has agreed to take a series of actions that align with the government’s new drug ...

Every year, we’re met with restructuring, hiring freezes, and portfolio cuts. And every year we tell ourselves the same story ...